IS4394A - Meðferðaefnasambönd, lyfjafræðilega hæf sölt og samsetningar sem innihalda efnasamböndin, ásamt notkun þeirra - Google Patents

Meðferðaefnasambönd, lyfjafræðilega hæf sölt og samsetningar sem innihalda efnasamböndin, ásamt notkun þeirra

Info

Publication number
IS4394A
IS4394A IS4394A IS4394A IS4394A IS 4394 A IS4394 A IS 4394A IS 4394 A IS4394 A IS 4394A IS 4394 A IS4394 A IS 4394A IS 4394 A IS4394 A IS 4394A
Authority
IS
Iceland
Prior art keywords
compounds
pharmaceutically acceptable
acceptable salts
compositions containing
therapeutic compounds
Prior art date
Application number
IS4394A
Other languages
English (en)
Other versions
IS1812B (is
Inventor
Dawes Chamberlain Stanley
Walter Koszalka George
Original Assignee
The Wellcome Foundation Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Wellcome Foundation Limited filed Critical The Wellcome Foundation Limited
Publication of IS4394A publication Critical patent/IS4394A/is
Publication of IS1812B publication Critical patent/IS1812B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IS4394A 1994-07-07 1996-12-09 Meðferðaefnasambönd, lyfjafræðilega hæf sölt og samsetningar sem innihalda efnasamböndin, ásamt notkun þeirra IS1812B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9413724A GB9413724D0 (en) 1994-07-07 1994-07-07 Therapeutic nucleosides
PCT/GB1995/001597 WO1996001833A1 (en) 1994-07-07 1995-07-06 Therapeutic compounds

Publications (2)

Publication Number Publication Date
IS4394A true IS4394A (is) 1996-12-09
IS1812B IS1812B (is) 2002-05-15

Family

ID=10757983

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4394A IS1812B (is) 1994-07-07 1996-12-09 Meðferðaefnasambönd, lyfjafræðilega hæf sölt og samsetningar sem innihalda efnasamböndin, ásamt notkun þeirra

Country Status (43)

Country Link
US (4) US6077832A (is)
EP (1) EP0769017B1 (is)
JP (1) JP3225045B2 (is)
KR (1) KR100376075B1 (is)
CN (2) CN1052010C (is)
AP (1) AP736A (is)
AT (1) ATE193298T1 (is)
AU (1) AU702248B2 (is)
BG (1) BG63435B1 (is)
BR (1) BR9508237A (is)
CY (1) CY2249B1 (is)
CZ (1) CZ290800B6 (is)
DE (1) DE69517172T2 (is)
DK (1) DK0769017T3 (is)
EE (1) EE03568B1 (is)
ES (1) ES2147294T3 (is)
FI (1) FI117629B (is)
GB (1) GB9413724D0 (is)
GE (1) GEP20002298B (is)
GR (1) GR3033744T3 (is)
HR (1) HRP950382B1 (is)
HU (1) HU227679B1 (is)
IL (1) IL114492A (is)
IS (1) IS1812B (is)
MD (1) MD1838G2 (is)
MX (1) MX9606732A (is)
MY (1) MY117892A (is)
NO (1) NO308854B1 (is)
NZ (1) NZ288722A (is)
OA (1) OA10339A (is)
PL (1) PL181136B1 (is)
PT (1) PT769017E (is)
RO (1) RO117699B1 (is)
RU (1) RU2145963C1 (is)
SA (1) SA95160202B1 (is)
SK (1) SK282046B6 (is)
TJ (1) TJ270B (is)
TR (1) TR199500832A2 (is)
TW (1) TW418196B (is)
UA (1) UA66744C2 (is)
WO (1) WO1996001833A1 (is)
YU (1) YU49443B (is)
ZA (1) ZA955644B (is)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9413724D0 (en) 1994-07-07 1994-08-24 Wellcome Found Therapeutic nucleosides
US5874413A (en) * 1995-08-18 1999-02-23 University Of Michigan 5'-substituted-ribofuranosyl benzimidazoles as antiviral agents
GB9518465D0 (en) * 1995-09-09 1995-11-08 Smithkline Beecham Seiyaku Kk Pharmaceuticals
GB9600142D0 (en) * 1996-01-05 1996-03-06 Wellcome Found Chemical compounds
GB9600143D0 (en) * 1996-01-05 1996-03-06 Wellcome Found Therapeutic compounds
AU1702597A (en) * 1996-01-23 1997-08-20 Glaxo Group Limited Modified benzimidazole nucleosides as antiviral agents
US6576133B2 (en) 1996-11-13 2003-06-10 Transgenomic, Inc Method and system for RNA analysis by matched ion polynucleotide chromatography
US6475388B1 (en) 1996-11-13 2002-11-05 Transgenomic, Inc. Method and system for RNA analysis by matched ion polynucleotide chromatography
GB2319961A (en) * 1996-12-07 1998-06-10 Glaxo Group Ltd Pharmaceutical composition for treatment of restenosis
AU6221998A (en) 1997-02-13 1998-09-08 Glaxo Group Limited Benzimidazole derivatives
ID24054A (id) * 1997-06-10 2000-07-06 Glaxo Group Ltd Glaxo Turunan turunan benzimidazol
CN1272113A (zh) 1997-07-30 2000-11-01 密歇根大学董事会 作为抗病毒剂的来苏呋喃糖基苯并咪唑类化合物
US6258264B1 (en) 1998-04-10 2001-07-10 Transgenomic, Inc. Non-polar media for polynucleotide separations
GB9807354D0 (en) 1998-04-07 1998-06-03 Glaxo Group Ltd Antiviral compound
GB9807355D0 (en) * 1998-04-07 1998-06-03 Glaxo Group Ltd Antiviral compound
US6277830B1 (en) * 1998-10-16 2001-08-21 Schering Corporation 5′-amino acid esters of ribavirin and the use of same to treat hepatitis C with interferon
US6576265B1 (en) 1999-12-22 2003-06-10 Acell, Inc. Tissue regenerative composition, method of making, and method of use thereof
GB0008939D0 (en) 2000-04-11 2000-05-31 Glaxo Group Ltd Process for preparing substituted benzimidazole compounds
RU2262344C2 (ru) * 2001-07-25 2005-10-20 Дж.Б.Кемикалс Энд Фармасьютикалс Лтд. Фармацевтическая композиция для лечения кожных инфекций и способ ее получения
RU2437892C2 (ru) * 2002-06-28 2011-12-27 Айденикс (Кайман) Лимитед Модифицированные 2- и 3-нуклеозиды и их применение для получения лекарственного средства, обладающего ингибирующей активностью в отношении вируса гепатита с
CA2530490A1 (en) 2003-06-25 2005-01-13 Stephen F. Badylak Conditioned matrix compositions for tissue restoration
WO2005063788A1 (ja) * 2003-12-26 2005-07-14 Kissei Pharmaceutical Co., Ltd. ベンズイミダゾール誘導体及びその医薬用途
RU2268741C1 (ru) * 2004-08-04 2006-01-27 Государственное образовательное учреждение высшего профессионального образования "Южно-Уральский государственный университет" Способ лечения герпетического поражения вестибулярного, спирального, тригеминального и коленчатого ганглиев
WO2006115137A1 (ja) * 2005-04-22 2006-11-02 Kissei Pharmaceutical Co., Ltd. ２－アミノベンズイミダゾール誘導体及びその医薬用途
EA008737B1 (ru) * 2005-12-07 2007-08-31 Леонид Андреевич Кожемякин Средство для профилактики и лечения конъюнктивитов и кератитов различной этиологии (варианты), способ его применения
US8546344B2 (en) 2010-10-28 2013-10-01 Viropharma Incorporated Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl)-1H-benzimidazole
US8940707B2 (en) * 2010-10-28 2015-01-27 Viropharma Incorporated Maribavir isomers, compositions, methods of making and methods of using
US8541391B2 (en) 2010-10-28 2013-09-24 Viropharma Incorporated Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl-1H-benzimidazole
US9447050B2 (en) 2011-04-05 2016-09-20 The Translational Genomics Research Institute Solid forms of curcumin
EP2867010A1 (en) 2012-06-29 2015-05-06 The Procter & Gamble Company Textured fibrous webs, apparatus and methods for forming textured fibrous webs
US9650376B2 (en) 2013-03-15 2017-05-16 Knopp Biosciences Llc Imidazo(4,5-B) pyridin-2-yl amides as KV7 channel activators
ES2960991T3 (es) 2014-09-12 2024-03-07 Biohaven Therapeutics Ltd Benzoimidazol-1,2-ilamidas como activadores del canal Kv7
WO2016086060A1 (en) * 2014-11-26 2016-06-02 The J. David Gladstone Institutes Methods for treating a cytomegalovirus infection
RU2629670C2 (ru) * 2016-08-04 2017-08-31 Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) 2-Амино-5,6-дифтор-1-(бета-D-рибофуранозил)-бензимидазол, способ получения и противовирусная активность его в отношении вируса герпеса простого 1-го типа
CN118955400A (zh) 2018-03-19 2024-11-15 诺普生物科学有限责任公司 Kv7通道激活剂组合物和使用方法
CN114096549A (zh) * 2020-06-23 2022-02-25 博美利克斯技术公司 新型苯并咪唑衍生物、其制备方法及其作为抗癌剂或者抗病毒剂的用途
HUE072879T2 (hu) 2022-10-12 2025-12-28 Takeda Pharmaceuticals Co A Maribavir elkészítési eljárása
WO2024103979A1 (zh) * 2022-11-17 2024-05-23 北京凯因科技股份有限公司 一种抑制疱疹病毒的化合物

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3399987A (en) * 1965-08-02 1968-09-03 United States Borax Chem 2-alkylaminobenzimidazoles as herbicides
CH443777A (de) * 1965-08-06 1968-02-15 Agripat Sa Verfahren zum Schützen textiler Keratinfasern vor Insektenfrass und Mittel zur Durchführung dieses Verfahrens
NL6716664A (is) * 1966-12-19 1968-06-20
US3655901A (en) * 1970-07-30 1972-04-11 Merck & Co Inc Method of inhibiting the formation of phenylethanalamine-n-methyl transferase with 2-aminobenzimidazoles
DE2130030A1 (de) * 1971-06-18 1972-12-21 Bayer Ag Fungizide und bakterizide Mittel
US4002623A (en) * 1974-08-07 1977-01-11 Pfizer Inc. Anti-inflammatory 1-[3-(dialkylamino)propyl]-2-acylaminobenzimidazoles and 2-acylamino-3-[3-(dialkylamino)-propyl]imidazo[4,5-b]pyridines
FR2549938B1 (fr) * 1983-07-25 1987-08-07 Fonderie Soc Gen De Bruleur a premelange gazeux et chaudiere equipee d'un tel bruleur
FR2551442B1 (fr) * 1983-09-05 1987-04-30 Centre Nat Rech Scient Nouveaux derives furaniques, leur preparation et leur application
CH667649A5 (en) * 1986-09-10 1988-10-31 Lonza Ag 2-Substd. amino-benzoxazole and -benzimidazole derivs. prodn. - by reacting prim. amino cpd. with amine in presence of acid catalyst, useful as intermediates e.g. for pharmaceuticals
EP0304624A3 (de) * 1987-07-29 1989-03-22 F. Hoffmann-La Roche Ag Benzimidazol-2-yl-pyridiniumverbindungen
IT1226100B (it) * 1988-07-07 1990-12-10 Dompe Farmaceutici Spa Derivati benzimidazolici farmacologicamente attivi.
DE3924424A1 (de) * 1989-07-24 1991-01-31 Boehringer Mannheim Gmbh Nucleosid-derivate, verfahren zu deren herstellung, deren verwendung als arzneimittel sowie deren verwendung bei der nucleinsaeure-sequenzierung
SE9003151D0 (sv) * 1990-10-02 1990-10-02 Medivir Ab Nucleoside derivatives
US5248672A (en) * 1990-11-01 1993-09-28 The Regents Of The University Of Michigan Polysubstituted benzimidazole nucleosides as antiviral agents
WO1992018517A1 (en) * 1991-04-17 1992-10-29 Yale University Method of treating or preventing hepatitis b virus
ZA923640B (en) * 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
EP0530407B1 (en) * 1991-09-04 1996-06-05 Stichting REGA V.Z.W. Substituted, nucleoside derivatives, methods for their preparation and pharmaceutical compositions containing them
US5314903A (en) * 1991-12-03 1994-05-24 Neurosearch A/S Benzimidazole compounds useful as calcium channel blockers
GB9205071D0 (en) * 1992-03-09 1992-04-22 Wellcome Found Therapeutic nucleosides
WO1994008456A1 (en) * 1992-10-21 1994-04-28 The Regents Of The University Of Michigan Polysubstituted benzimidazoles as antiviral agents
US5399580A (en) * 1993-03-08 1995-03-21 Burroughs Wellcome Co. Therapeutic nucleosides-uses
GB9413724D0 (en) * 1994-07-07 1994-08-24 Wellcome Found Therapeutic nucleosides
JP6217655B2 (ja) * 2015-01-15 2017-10-25 トヨタ自動車株式会社 電力変換装置

Also Published As

Publication number Publication date
AP736A (en) 1999-03-09
RU2145963C1 (ru) 2000-02-27
GEP20002298B (en) 2000-11-25
HU9700034D0 (en) 1997-02-28
FI970032L (fi) 1997-01-03
TR199500832A2 (tr) 1996-06-21
ES2147294T3 (es) 2000-09-01
HRP950382A2 (en) 1997-08-31
YU49443B (sh) 2006-03-03
AU2805195A (en) 1996-02-09
EP0769017A1 (en) 1997-04-23
CN1236616A (zh) 1999-12-01
EP0769017B1 (en) 2000-05-24
PT769017E (pt) 2000-09-29
CZ290800B6 (cs) 2002-10-16
AP9600895A0 (en) 1997-01-31
MX9606732A (es) 1997-04-30
ZA955644B (en) 1997-01-06
OA10339A (en) 1997-10-07
AU702248B2 (en) 1999-02-18
FI970032A0 (fi) 1997-01-03
MY117892A (en) 2004-08-30
NO308854B1 (no) 2000-11-06
ATE193298T1 (de) 2000-06-15
BG101118A (en) 1998-04-30
IL114492A0 (en) 1995-11-27
WO1996001833A1 (en) 1996-01-25
PL318062A1 (en) 1997-05-12
NO970040L (no) 1997-01-29
US20010003744A1 (en) 2001-06-14
HK1003711A1 (en) 1998-11-06
SK282046B6 (sk) 2001-10-08
RO117699B1 (ro) 2002-06-28
DK0769017T3 (da) 2000-09-11
TJ270B (en) 2000-08-07
GB9413724D0 (en) 1994-08-24
DE69517172D1 (de) 2000-06-29
EE9700013A (et) 1997-06-16
FI117629B (fi) 2006-12-29
UA66744C2 (en) 2004-06-15
JP3225045B2 (ja) 2001-11-05
BR9508237A (pt) 1999-06-01
NO970040D0 (no) 1997-01-06
KR100376075B1 (ko) 2004-02-18
YU45095A (sh) 1999-03-04
US6077832A (en) 2000-06-20
GR3033744T3 (en) 2000-10-31
HRP950382B1 (en) 2000-12-31
CN1159194A (zh) 1997-09-10
US6307043B1 (en) 2001-10-23
HU227679B1 (en) 2011-11-28
SK168896A3 (en) 1997-09-10
MD1838F2 (en) 2002-01-31
HUT77285A (hu) 1998-03-30
TW418196B (en) 2001-01-11
DE69517172T2 (de) 2000-10-19
IS1812B (is) 2002-05-15
IL114492A (en) 2002-05-23
CY2249B1 (en) 2003-07-04
JPH10502356A (ja) 1998-03-03
PL181136B1 (pl) 2001-06-29
SA95160202B1 (ar) 2005-04-16
CZ4097A3 (en) 1997-08-13
US5998605A (en) 1999-12-07
EE03568B1 (et) 2001-12-17
BG63435B1 (bg) 2002-01-31
NZ288722A (en) 1998-07-28
CN1052010C (zh) 2000-05-03
MD1838G2 (ro) 2002-08-31

Similar Documents

Publication Publication Date Title
IS4394A (is) Meðferðaefnasambönd, lyfjafræðilega hæf sölt og samsetningar sem innihalda efnasamböndin, ásamt notkun þeirra
NL300952I2 (nl) Peramivir en farmaceutisch aanvaardbare zouten daarvan
NO20053106D0 (no) Oral, analgesisk doseringsform med forlenget frigivelse.
EE200000468A (et) Ühendid, nende kasutamine ja farmatseutiline kompositsioon
IS3878A (is) Imidazodiazepines efnasambönd, framleiðsla þeirraog notkun sem lyfja
FI941378L (fi) Bentsimidatsoliyhdisteitä, niiden käyttö ja valmistus
NO975831D0 (no) Nytt farmasöytisk preparat med anestetisk virkning
GB9515775D0 (en) Piperidine derivatives and their use as therapeutic agents
ITRM920412A1 (it) Eteroprostanoidi, procedimento per la loro preparazione e loro impiego terapeutico.
EP0518818A3 (en) Arylethers, their manufacture and use as medicament
FI956298A0 (fi) 3-fenyyli-isokinolin-1(2H)-oneja, niiden valmistus ja terapeuttinen käyttö
PL317613A1 (en) Substituted aryloalkylothioalkyl thiopyridines for fighting against heliobacter
FI970997L (fi) Bentsosykloalkeeniyhdisteet, niiden valmistus ja käyttö
FI964212L (fi) Röntgenvarjoainekoostumuksia, jotka sisältävät farmaseuttisesti hyväksyttäviä savia
NO940130D0 (no) Benzimidazolderivater, fremgangsmaate for deres fremstilling og te rapeutisk anvendelse derav
NO308213B1 (no) Substituerte indanylidinacetylguanidiner, deres anvendelse og medikamenter inneholdende forbindelsene
DE68906245D1 (de) Therapeutisches mittel gegen aids.
FI943875L (fi) 2,3,4,5-Tetrahydro-1H-3-bentsatsepiinejä ja niiden farmaseuttisesti hyväksyttäviä happoadditiosuoloja
PL317615A1 (en) Thiopyridines for fighting against heliobacter
GB9816897D0 (en) Therapeutic use
HU9600660D0 (en) Butenol-triazolyl derivatives, their manufacture and use as microbicides
FI942265A7 (fi) 2-aminopyratsin-5-karboksamidijohdannaiset, niiden valmistus ja terapeuttinen käyttö
FI972637A0 (fi) K-ryhmän vitamiinin käyttö lisäkilpirauhasen liikatoiminnan hoitoon
GB9821179D0 (en) Therapeutic use
GB9423948D0 (en) Heterocyclic compounds, their preparation and their therapeutic use